Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

[1]  Chin-Lee Wu,et al.  Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study. , 2003, Human pathology.

[2]  S. Murata,et al.  Expression of Thyroid Transcription Factor-1 in Normal and Neoplastic Lung Tissues , 2002, Modern Pathology.

[3]  S. Lau,et al.  Thyroid Transcription Factor-1: A Review , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[4]  Y. Yatabe,et al.  TTF-1 Expression in Pulmonary Adenocarcinomas , 2002, The American journal of surgical pathology.

[5]  V. Torri,et al.  HER‐2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma , 2002, Cancer.

[6]  G. Bepler,et al.  MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Copin,et al.  Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas. , 2001, Human pathology.

[8]  G. Pelosi,et al.  Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung , 2001, The American journal of surgical pathology.

[9]  K. Franssila,et al.  Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. , 2000, Human pathology.

[10]  N. Ordóñez,et al.  Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. , 2000, The American journal of surgical pathology.

[11]  N. Ordóñez,et al.  Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. , 2000, Advances in anatomic pathology.

[12]  Dietel,et al.  Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B , 2000, Histopathology.

[13]  J. Whitsett,et al.  Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. , 1999, Human pathology.

[14]  F. Puglisi,et al.  Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  R. Warnick,et al.  Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1 , 1998, Journal of Neuro-Oncology.

[16]  J. Whitsett,et al.  Thyroid Transcription Factor-1 and Cytokeratins 7 and 20 in Pulmonary and Breast Carcinoma , 1998, Acta Cytologica.

[17]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[18]  F. Puglisi,et al.  TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. , 1998, Cancer letters.

[19]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[20]  F. Puglisi,et al.  Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. , 1997, Journal of clinical pathology.

[21]  R. Schwartz,et al.  Transcriptional regulation of a mouse Clara cell-specific protein (mCC10) gene by the NKx transcription factor family members thyroid transciption factor 1 and cardiac muscle-specific homeobox protein (CSX) , 1996, Molecular and cellular biology.

[22]  R. Lauro,et al.  Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[23]  C. di Loreto,et al.  TTF-1 gene expression in human lung tumours. , 1996, European journal of cancer.

[24]  J. Whitsett,et al.  Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. , 1996, Hybridoma.

[25]  J. Whitsett,et al.  Lung Cell-specific Expression of the Murine Surfactant Protein A (SP-A) Gene Is Mediated by Interactions between the SP-A Promoter and Thyroid Transcription Factor-1 (*) , 1995, The Journal of Biological Chemistry.

[26]  R. Lauro,et al.  Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. , 1994, Cancer research.

[27]  S. Steinberg,et al.  Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. , 1992, American journal of clinical pathology.

[28]  R. Lauro,et al.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. , 1991, Development.

[29]  M. Mattéi,et al.  Thyroid nuclear factor 1 (TTF‐1) contains a homeodomain and displays a novel DNA binding specificity. , 1990, The EMBO journal.

[30]  W. Gehring,et al.  Homeo boxes in the study of development. , 1987, Science.

[31]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[32]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[33]  Rochelle L. Garcia,et al.  Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[34]  C H Fox,et al.  The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.

[35]  D. Cox.  Regression Models and Life-Tables , 1972 .